Ideas to Action:

Independent research for global prosperity



June 23, 2010

FDA’s Role in Improving the Development Pathway for Neglected Disease Therapies - Congressional Testimony

Visiting Fellow Tom Bollyky testified before the U.S. Senate Appropriations Subcommittee on Agriculture, Rural Development, the Food and Drug Administration, and Related Agencies on how the FDA can help develop programs for neglected diseases. Programs for neglected diseases, such as tuberculosis, malaria and other parasitic illnesses, lack a regulatory infrastructure to ensure programs work properly.